Výsledky vyhledávání

Akademický článek

TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry.

Autor: Baggen J; KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute, Leuven 3000, Belgium. Electronic address: jim.baggen@kuleuven.be., Jacquemyn M; KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute, Leuven 3000, Belgium., Persoons L; KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute, Leuven 3000, Belgium., Vanstreels E; KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute, Leuven 3000, Belgium., Pye VE; Chromatin Structure and Mobile DNA Laboratory, Francis Crick Institute, London NW1 1AT, UK., Wrobel AG; Structural Biology of Disease Processes Laboratory, Francis Crick Institute, London NW1 1AT, UK., Calvaresi V; Department of Chemistry, Britannia House, 7 Trinity Street, King's College London, London SE1 1DB, UK., Martin SR; Structural Biology of Disease Processes Laboratory, Francis Crick Institute, London NW1 1AT, UK., Roustan C; Structural Biology Science Technology Platform, Francis Crick Institute, London NW1 1AT, UK., Cronin NB; LonCEM Facility, Francis Crick Institute, London NW1 1AT, UK., Reading E; Department of Chemistry, Britannia House, 7 Trinity Street, King's College London, London SE1 1DB, UK., Thibaut HJ; KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Translational Platform Virology and Chemotherapy, Rega Institute, Leuven 3000, Belgium., Vercruysse T; KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Translational Platform Virology and Chemotherapy, Rega Institute, Leuven 3000, Belgium., Maes P; KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical and Epidemiological Virology, Rega Institute, Leuven 3000, Belgium., De Smet F; KU Leuven Department of Imaging and Pathology, Laboratory for Precision Cancer Medicine, Translational Cell and Tissue Research Unit, Leuven 3000, Belgium., Yee A; Alector LLC, 131 Oyster Point Blvd. Suite 600, South San Francisco, CA 94080, USA., Nivitchanyong T; Alector LLC, 131 Oyster Point Blvd. Suite 600, South San Francisco, CA 94080, USA., Roell M; Alector LLC, 131 Oyster Point Blvd. Suite 600, South San Francisco, CA 94080, USA., Franco-Hernandez N; Alector LLC, 131 Oyster Point Blvd. Suite 600, South San Francisco, CA 94080, USA., Rhinn H; Alector LLC, 131 Oyster Point Blvd. Suite 600, South San Francisco, CA 94080, USA., Mamchak AA; Alector LLC, 131 Oyster Point Blvd. Suite 600, South San Francisco, CA 94080, USA., Ah Young-Chapon M; Alector LLC, 131 Oyster Point Blvd. Suite 600, South San Francisco, CA 94080, USA., Brown E; Alector LLC, 131 Oyster Point Blvd. Suite 600, South San Francisco, CA 94080, USA., Cherepanov P; Chromatin Structure and Mobile DNA Laboratory, Francis Crick Institute, London NW1 1AT, UK; Department of Infectious Disease, Section of Virology, Imperial College London, St Mary's Campus, Norfolk Place, London W2 1PG, UK. Electronic address: peter.cherepanov@crick.ac.uk., Daelemans D; KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute, Leuven 3000, Belgium. Electronic address: dirk.daelemans@kuleuven.be.

Publikováno v: Cell [Cell] 2023 Aug 03; Vol. 186 (16), pp. 3427-3442.e22. Date of Electronic Publication: 2023 Jul 07.

Zobrazit plný text záznamu

Akademický článek

Multi-Donor Longitudinal Antibody Repertoire Sequencing Reveals the Existence of Public Antibody Clonotypes in HIV-1 Infection.

Autor: Setliff I; Program in Chemical & Physical Biology, Vanderbilt University Medical Center, Nashville, TN, USA; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA., McDonnell WJ; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA; Center for Translational Immunology and Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, USA., Raju N; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA., Bombardi RG; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA., Murji AA; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA., Scheepers C; Center for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Ziki R; Center for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa., Mynhardt C; Center for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa., Shepherd BE; Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA., Mamchak AA; ATRECA, Inc, 500 Saginaw Dr., Redwood City, CA, USA., Garrett N; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa., Karim SA; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA., Mallal SA; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA; Center for Translational Immunology and Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, USA; Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, USA; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, WA, Australia., Crowe JE Jr; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA., Morris L; Center for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa., Georgiev IS; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Electrical Engineering and Computer Science, Vanderbilt University, Nashville, TN, USA. Electronic address: ivelin.georgiev@vanderbilt.edu.

Publikováno v: Cell host & microbe [Cell Host Microbe] 2018 Jun 13; Vol. 23 (6), pp. 845-854.e6. Date of Electronic Publication: 2018 May 31.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání